Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 1.00 |
| ▸ | MAPT | P10636 | 7/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 6/20 | 1.00 |
| ▸ | SLCO1B3 | Q9NPD5 | 2/20 | 1.00 |
| ▸ | SLCO1B1 | Q9Y6L6 | 2/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.74 |
| ▸ | APP | P05067 | 4/20 | 0.71 |
| ▸ | SNCA | P37840 | 4/20 | 0.71 |
| ▸ | RBP4 | P02753 | 4/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.71 |
| ▸ | MEN1 | O00255 | 2/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.71 |
| ▸ | TSHR | P16473 | 2/20 | 0.71 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.71 |
| ▸ | USP2 | O75604 | 1/20 | 0.71 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gilretinol Acetate SCHEMBL14204855 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4SLCO1B3SLCO1B1 | |
| Gilretinol Acetate SCHEMBL28272980 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4SLCO1B3SLCO1B1 | |
| Gilretinol Acetate SCHEMBL3332545 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4SLCO1B3SLCO1B1 | |
| Gilretinol Acetate SCHEMBL21588 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4SLCO1B3SLCO1B1 | |
| Zuretinol Acetate SCHEMBL1173917 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4SLCO1B3SLCO1B1 | |
| Gilretinol Acetate SCHEMBL1363443 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4SLCO1B3SLCO1B1 | |
| Gilretinol Acetate SCHEMBL21589 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4SLCO1B3SLCO1B1 | |
| Gilretinol Acetate SCHEMBL7021710 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4SLCO1B3SLCO1B1 | |
| Gilretinol Acetate SCHEMBL22636388 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4SLCO1B3SLCO1B1 | |
| Gilretinol Acetate SCHEMBL10928186 | 0.99 | ALDH1A1 (0.98) | ALDH1A1MAPTCYP3A4SLCO1B3SLCO1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114127273-A | Novel beta-carotene oxidase | 帝斯曼知识产权资产管理有限公司 | 2022-03-01 | — | — | CN | claimed |
| CN-111107832-A | Production of retinyl esters | 帝斯曼知识产权资产管理有限公司 | 2020-05-05 | — | — | CN | claimed |
| CN-111107834-A | Biosynthesis of retinoids | 帝斯曼知识产权资产管理有限公司 | 2020-05-05 | — | — | CN | claimed |
| CN-119699475-A | Use of berberine alkaloid in preventing and/or treating intestinal diseases | IRP健康股份有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-118354768-A | Novel compositions | 帝斯曼知识产权资产管理有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-118119700-A | Retinoid production | 帝斯曼知识产权资产管理有限公司 | 2024-05-31 | — | — | CN | disclosed |
| US-20220356503-A1 | NOVEL BETA-CAROTENE OXIDASES | DSM IP ASSETS B.V. (NL) | 2022-11-10 | — | — | US | disclosed |
| EP-3999634-A1 | NOVEL BETA-CAROTENE OXIDASES | DSM IP Assets B.V. (NL) | 2022-05-25 | — | — | EP | disclosed |
| CN-114127273-A | Novel beta-carotene oxidase | 帝斯曼知识产权资产管理有限公司 | 2022-03-01 | — | — | CN | disclosed |
| CN-107567493-B | Bacillus strains for improving the health and performance of production animals | 诺维信公司 | 2021-11-16 | — | — | CN | disclosed |
| WO-2021009194-A1 | NOVEL BETA-CAROTENE OXIDASES | DSM IP ASSETS B.V. (NL) | 2021-01-21 | — | — | WO | disclosed |
| CN-111107834-A | Biosynthesis of retinoids | 帝斯曼知识产权资产管理有限公司 | 2020-05-05 | — | — | CN | disclosed |
| CN-111107832-A | Production of retinyl esters | 帝斯曼知识产权资产管理有限公司 | 2020-05-05 | — | — | CN | disclosed |
| CN-110709080-A | Use of berberine alkaloid preparation in preventing and/or treating infectious diseases | IRP健康股份有限公司 | 2020-01-17 | — | — | CN | disclosed |
| CN-110650739-A | Use of berberine alkaloid in preventing and/or treating intestinal diseases | IRP健康股份有限公司 | 2020-01-03 | — | — | CN | disclosed |
| CN-102976937-B | For treating retinoid and the using method thereof of visual disorder | 华盛顿大学 | 2016-12-21 | — | — | CN | disclosed |
| US-6348622-B1 | CHEMICAL INTERMEDIATES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-02-19 | — | — | US | disclosed |
| US-6329414-B1 | SYNTHETIC OR NATURALLY OCCURRING PHYTONUTRIENT OF CANTHANAXIN, LIMONENE AND/OR VITAMIN A; CYTOPROTECTIVE SELECTED FROM D- OR L-HISTIDINE, RACEMIC, NON-RACEMIC MIXTURE, NUTRICEUTICALLY INERT CARRIER, SUCH AS MICROCRYSTALLINE CELLULOSE | CYTOS PHARMACEUTICALS LLC | 2001-12-11 | — | — | US | disclosed |
| US-5972985-A | CYTO-PROTECTIVE AGENT SELECTED FROM THE GROUP CONSISTING OF D-HISTIDINE, L-HISTIDINE, A RACEMIC MIXTURE THEREOF, A PHYTONUTRIENT HAVING ANTIOXIDANT ACTIVITY SELECTED FROM CAROTENOIDS, FLAVONOIDS, TOCOPHEROLS, ASCORBATES | CYTOS PHARMACEUTICALS, LLC (US) | 1999-10-26 | — | — | US | disclosed |
| EP-0900785-A2 | Vitamin A related compounds and process for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-03-10 | — | — | EP | disclosed |